Literature DB >> 9833866

Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.

P Hegener, P F Troke, G Fätkenheuer, V Diehl, M Ruhnke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9833866

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  12 in total

Review 1.  [Anti-fungal drugs. Current status and guidelines for their administration].

Authors:  Rodrigo Fernández Alonso; Maria Esther González García; Joaquín Fernández García; Francisco Javier Cepeda Piorno
Journal:  Clin Transl Oncol       Date:  2005-10       Impact factor: 3.405

2.  Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.

Authors:  M A Pfaller; D J Diekema; J H Rex; A Espinel-Ingroff; E M Johnson; D Andes; V Chaturvedi; M A Ghannoum; F C Odds; M G Rinaldi; D J Sheehan; P Troke; T J Walsh; D W Warnock
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

3.  Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.

Authors:  E S Dodds Ashley; A K Zaas; A F Fang; B Damle; J R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

Review 4.  Oropharyngeal candidiasis in the era of antiretroviral therapy.

Authors:  George R Thompson; Payal K Patel; William R Kirkpatrick; Steven D Westbrook; Deborah Berg; Josh Erlandsen; Spencer W Redding; Thomas F Patterson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-02-13

5.  Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.

Authors:  Jigar V Desai; Amanda Urban; Michail S Lionakis; Alexandra F Freeman; Doris Z Swaim; Benjamin Colton; Lilian W Kibathi; Elise M N Ferrè; Pamela Stratton; Melissa A Merideth; Sally Hunsberger; Theresa Matkovits; Raphael Mannino; Steven M Holland; Edmund Tramont
Journal:  Antimicrob Agents Chemother       Date:  2022-06-14       Impact factor: 5.938

6.  Validated LC Method for the Estimation of Voriconazole in Bulk and Formulation.

Authors:  C N Patel; J B Dave; J V Patel; B Panigrahi
Journal:  Indian J Pharm Sci       Date:  2009-11       Impact factor: 0.975

7.  Toward Harmonization of Voriconazole CLSI and EUCAST Breakpoints for Candida albicans Using a Validated In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Maria-Ioanna Beredaki; Panagiota-Christina Georgiou; Maria Siopi; Lamprini Kanioura; David Andes; Maiken Cavling Arendrup; Johan W Mouton; Joseph Meletiadis
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

8.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

9.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

Review 10.  Mucosal and systemic fungal infections in patients with AIDS: prophylaxis and treatment.

Authors:  Markus Ruhnke
Journal:  Drugs       Date:  2004       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.